Caring Brands (CABR) Q1 2026 earnings summary

Executive summary

• Report covers the quarter ended March 31, 2026, for a wellness consumer products company focused on OTC and prescription-grade health and wellness products.

• The company is in early commercialization, with minimal revenue and ongoing operating losses as it advances its business plan.

• Management believes existing cash resources are sufficient for at least the next twelve months, but additional capital may be required.

Financial highlights

• No revenue was generated for the three months ended March 31, 2026, compared to $1,469 in the prior year period.

• Operating loss increased to $1,721,499 from $539,343 year-over-year, driven by higher payroll, stock-based compensation, and professional service fees.

• Net loss for the quarter was $2,008,476, compared to $538,770 in the prior year.

• Accretion to redeemable preferred equity of $1,844,607 resulted in a net loss attributable to common stockholders of $3,853,083.

• Cash and cash equivalents were $2,033,438 as of March 31, 2026, down from $2,189,232 at year-end 2025.

Outlook and guidance

• Management expects existing cash to fund operations for at least the next twelve months but may seek additional capital for long-term growth or strategic initiatives.

• The company continues to focus on product development and commercialization, with no meaningful commercial revenue yet.